Globus Medical has been actively pursuing growth through strategic acquisitions and mergers. The company’s all-stock merger with NuVasive (NASDAQ:NUVA) has created a formidable player in the ...

Globus Medical is a medical device company specializing ... which has now completed one year since the acquisition of NuVasive Inc. A doctor in a medical facility demonstrating a procedure with ...

The repayment of debt and strong free cash flow are significant milestones for Globus Medical, especially following the financial obligations from the NuVasive merger. The company’s ability to ...

Despite these challenges, Globus Medical achieved a record level of free cash flow for a first quarter and successfully repaid all outstanding debt from the NuVasive merger, emerging with no debt on ...

Management has reported that synergy targets from the NuVasive acquisition remain on track, contributing to what some analysts describe as one of the most successful spine mergers in history.

Globus Medical is a medical device company specializing ... which has now completed one year since the acquisition of NuVasive Inc. The downgrade also reflects negative cross-reads from industry ...

Globus Medical, Inc. price | Globus Medical, Inc. Quote Globus Medical merged its business with NuVasive. The combined company has formed a global musculoskeletal company focused on rapid ...

Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On ...

Key players in the global orthopedic devices include Zimmer Biomet, Stryker Corporation, DePuy Synthes (Johnson & Johnson), Smith & Nephew, Medtronic, Arthrex, Globus Medical (NuVasive Inc.), Orthofix ...

Globus Medical has been actively pursuing growth through strategic acquisitions and mergers. The company’s all-stock merger with NuVasive (NASDAQ:NUVA) has created a formidable player in the spine ...

BTIG analysts have downgraded Globus Medical (NYSE:GMED ... of cracks in the company’s Spine unit a year after integrating NuVasive. According to the analysts, every company in the spine ...